Burkholderia cepacia: medical, taxonomic and ecological issues - PubMed (original) (raw)
Review
Burkholderia cepacia: medical, taxonomic and ecological issues
J R Govan et al. J Med Microbiol. 1996 Dec.
Abstract
The increasing challenge posed by multiresistant saprophytes in medical microbiology is strikingly demonstrated by the emergence of Burkholderia (formerly Pseudomonas) cepacia as an opportunist pathogen in immunocompromised patients, particularly individuals with chronic granulomatous disease and cystic fibrosis (CF). Best known previously as a phytopathogen and the cause of soft rot of onions, B. cepacia presents three major problems for the CF community: innate multiresistance to antimicrobial agents; person-to-person transmission of epidemic strains through nosocomial or social contacts; and 'cepacia syndrome', a fulminating fatal pneumonia, sometimes associated with septicaemia, that occurs in approximately 20% of colonised patients, including those with previously mild disease. Accumulated evidence to dispel earlier suggestions that the organism is avirulent and merely a marker of existing lung disease includes: case-controlled studies in CF patients; reports of serious infections in non-CF patients; in-vitro and in-vivo evidence that B. cepacia induces production of pro-inflammatory markers, including the major cytokine TNFalpha; and histopathological evidence that exposure of transgenic CF mice to B. cepacia results in pneumonia. By the early 1990s, the use of selective culture media and DNA-based bacterial fingerprinting confirmed suspicions of epidemic person-to-person spread of B. cepacia. This evidence provided scientific justification for draconian and controversial measures for infection control, in particular, segregation of B. cepacia-colonised patients during treatment at CF centres and their exclusion from social gatherings and national conferences. Recently, molecular analyses of type strains and clinical isolates have revealed that isolates identified previously as B. cepacia belong to at least three distinct species and have increased concern regarding the reliability of current laboratory detection and identification systems. Clarification of the taxonomy of B. cepacia-like organisms and the pathogenic potential of environmental isolates remains a high priority, particularly when the organism's antifungal and degradative properties have created interest in its potential use as a biological control agent to improve crop yields and its use for the bioremediation of contaminated soils.
Similar articles
- [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
Segonds C, Chabanon G. Segonds C, et al. Ann Biol Clin (Paris). 2001 May-Jun;59(3):259-69. Ann Biol Clin (Paris). 2001. PMID: 11397673 Review. French. - Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
Revets H, Vandamme P, Van Zeebroeck A, De Boeck K, Struelens MJ, Verhaegen J, Ursi JP, Verschraegen G, Franckx H, Malfroot A, Dab I, Lauwers S. Revets H, et al. Acta Clin Belg. 1996;51(4):222-30. doi: 10.1080/22953337.1996.11718514. Acta Clin Belg. 1996. PMID: 8858887 - [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
Baylan O. Baylan O. Mikrobiyol Bul. 2012 Apr;46(2):304-18. Mikrobiyol Bul. 2012. PMID: 22639321 Review. Turkish. - Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.
Sajjan U, Corey M, Humar A, Tullis E, Cutz E, Ackerley C, Forstner J. Sajjan U, et al. J Med Microbiol. 2001 Jun;50(6):535-546. doi: 10.1099/0022-1317-50-6-535. J Med Microbiol. 2001. PMID: 11393291 - The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia.
Spencer RC. Spencer RC. J Hosp Infect. 1995 Jun;30 Suppl:453-64. doi: 10.1016/0195-6701(95)90049-7. J Hosp Infect. 1995. PMID: 7560984 Review.
Cited by
- Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.
Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Høiby N, Schwartz M, Koch C. Garred P, et al. J Clin Invest. 1999 Aug;104(4):431-7. doi: 10.1172/JCI6861. J Clin Invest. 1999. PMID: 10449435 Free PMC article. - Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.
Coenye T, Spilker T, Martin A, LiPuma JJ. Coenye T, et al. J Clin Microbiol. 2002 Sep;40(9):3300-7. doi: 10.1128/JCM.40.9.3300-3307.2002. J Clin Microbiol. 2002. PMID: 12202570 Free PMC article. - Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia.
Bernier SP, Sokol PA. Bernier SP, et al. J Bacteriol. 2005 Aug;187(15):5278-91. doi: 10.1128/JB.187.15.5278-5291.2005. J Bacteriol. 2005. PMID: 16030222 Free PMC article. - Detection of heme-binding proteins in epidemic strains of Burkholderia cepacia.
Smalley JW, Charalabous P, Birss AJ, Hart CA. Smalley JW, et al. Clin Diagn Lab Immunol. 2001 May;8(3):509-14. doi: 10.1128/CDLI.8.3.509-514.2001. Clin Diagn Lab Immunol. 2001. PMID: 11329449 Free PMC article. - Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study.
Cunha MV, Leitão JH, Mahenthiralingam E, Vandamme P, Lito L, Barreto C, Salgado MJ, Sá-Correia I. Cunha MV, et al. J Clin Microbiol. 2003 Sep;41(9):4113-20. doi: 10.1128/JCM.41.9.4113-4120.2003. J Clin Microbiol. 2003. PMID: 12958234 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases